Delivery Order SPE2DB22D1017-SPE2DB24FF7BD
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,892,054 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price, delivery order with a ceiling value of $14,288.86 and an ultimate completion date of September 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,819.05, is for the supply of 4,567,943,593 units of the drug Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 17, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,308,593 units of Cimzia 2x200 mg/mL syringe kits, a specialty pharmaceutical product. The contract has a firm fixed price of $37,453.55 and a completion date of August 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,108,607 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $25,267.75. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,451,455 units of CIMZIA 2X200 MG/ML syringe kits, with a firm fixed price of $15,078.48 and a completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,379,479 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a ceiling value of $28,803.46 and is a firm fixed-price, delivery order type contract with a period of performance through August 8, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,957 units of the medication Cimzia 2x200 mg/ml syringe kits. The contract has a ceiling value of $19,419.25 and a period of performance through April 18, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,942,875 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,911.81. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The ultimate completion date for this order is April 17, 2025. AmerisourceBergen Drug...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for 4,566,110,970 units of CIMZIA 2X200 MG/ML Syringe Kits, a specialty pharmaceutical product. The order has a ceiling value of $11,992.63 and is a firm fixed-price contract with an ultimate completion date of October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various government...
- This is a Delivery Order contract award to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $9,310.86, is for the delivery of 4,565,862,285 units of CIMZIA 2X200 MG/ML syringe kits. The contract has a firm fixed price pricing type and an ultimate completion date of September 19, 2024. This award does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7BDDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for 4,564,478,670 units of the pharmaceutical product Cimzia 2x200 mg/ml syringe kits. The contract has a firm fixed-price pricing type and a ceiling value of $12,529.87. It has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This delivery order is likely placed against that IDC. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 5/2/24 |